Research programme: viral entry inhibitors - Samaritan
Alternative Names: SP 10; SP 10T1; SP-03; SP-30Latest Information Update: 02 Oct 2021
At a glance
- Originator Georgetown University
- Class Benzamides; Quinuclidines
- Mechanism of Action Virus internalisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis C; HIV infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hepatitis-C in USA (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in USA (PO)
- 06 Aug 2007 Preclinical data added to the viral infections antimicrobial and pharmacodynamics sections